Proteome Sciences (PRM) Competitors GBX 1.51 -0.44 (-22.37%) As of 10/17/2025 11:54 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock PRM vs. VGAS, ALB, ADES, LOOP, PPG, REX, SMG, PCT, SLI, and LTHMShould you be buying Proteome Sciences stock or one of its competitors? The main competitors of Proteome Sciences include Volga Gas (VGAS), Albert Technologies (ALB), ADES International (ADES), LoopUp Group (LOOP), Plutus PowerGen (PPG), 3260041 (REX.L) (REX), 646143 (SMG.L) (SMG), Polar Capital Technology Trust (PCT), Standard Life Investments Property Income Trust (SLI), and James Latham (LTHM). These companies are all part of the "chemicals" industry. Proteome Sciences vs. Its Competitors Volga Gas Albert Technologies ADES International LoopUp Group Plutus PowerGen 3260041 (REX.L) 646143 (SMG.L) Polar Capital Technology Trust Standard Life Investments Property Income Trust James Latham Volga Gas (LON:VGAS) and Proteome Sciences (LON:PRM) are both small-cap chemicals companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership. Is VGAS or PRM more profitable? Volga Gas has a net margin of 0.00% compared to Proteome Sciences' net margin of -0.04%. Volga Gas' return on equity of 0.00% beat Proteome Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Volga GasN/A N/A N/A Proteome Sciences -0.04%-0.01%-19.25% Does the media prefer VGAS or PRM? In the previous week, Volga Gas' average media sentiment score of 0.00 equaled Proteome Sciences'average media sentiment score. Company Overall Sentiment Volga Gas Neutral Proteome Sciences Neutral Do institutionals and insiders hold more shares of VGAS or PRM? 0.0% of Proteome Sciences shares are owned by institutional investors. 37.4% of Proteome Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, VGAS or PRM? Volga Gas has higher revenue and earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Volga Gas, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVolga Gas£18.73M0.00N/A-£19.20N/AProteome Sciences£4.53M0.98-£4.08M-£0.01-133.63 SummaryVolga Gas beats Proteome Sciences on 5 of the 8 factors compared between the two stocks. Get Proteome Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRM vs. The Competition Export to ExcelMetricProteome SciencesDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£4.46M£48.22M£6.09B£2.57BDividend Yield6.17%3.87%5.73%5.32%P/E Ratio-133.630.9984.984,280.30Price / Sales0.98544.41519.6899,406.89Price / Cash3.7311.4237.1627.90Price / Book-0.852.8412.238.11Net Income-£4.08M£334.07B£3.33B£5.89B7 Day Performance-31.36%-0.65%1.18%-0.62%1 Month Performance-49.67%-5.88%6.16%0.88%1 Year Performance-46.26%-1.00%60.00%126.01% Proteome Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRMProteome SciencesN/AGBX 1.51-22.4%N/A-40.1%£4.46M£4.53M-133.63240Gap UpHigh Trading VolumeVGASVolga GasN/AN/AN/AN/A£18.99M£18.73M-1.222ALBAlbert TechnologiesN/AN/AN/AN/A£7.98M£4.61M-0.537,400Gap UpHigh Trading VolumeADESADES InternationalN/AN/AN/AN/A£5.09M£452.11M26.62140LOOPLoopUp GroupN/AN/AN/AN/A£1.43M£22.07M-5.8390PPGPlutus PowerGenN/AN/AN/AN/A£1.32M£1.17M-0.1952,000REX3260041 (REX.L)N/AN/AN/AN/A£0.00N/A0.00120SMG646143 (SMG.L)N/AN/AN/AN/A£0.00N/A0.006,100High Trading VolumePCTPolar Capital Technology TrustN/AGBX 432.50-2.6%N/A+36.8%£4.94B£122.39M4,338.01120Positive NewsHigh Trading VolumeSLIStandard Life Investments Property Income TrustN/AN/AN/AN/A£312.43M£29.95M3.672,021LTHMJames LathamN/AGBX 1,025-3.3%N/A-26.8%£206.64M£366.61M1,140.161,350News CoverageDividend CutGap Down Related Companies and Tools Related Companies Volga Gas Competitors Albert Technologies Competitors ADES International Competitors LoopUp Group Competitors Plutus PowerGen Competitors 3260041 (REX.L) Competitors 646143 (SMG.L) Competitors Polar Capital Technology Trust Competitors Standard Life Investments Property Income Trust Competitors James Latham Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PRM) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBankrupt to billionaire after retirement?Expert Reveals: The #1 Retirement Play for 2025 "We're Entering the Greatest Energy Bull Market Since the I...Brownstone Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteome Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
